Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.
Apar Kishor GantiMichael RothePam K MangatElizabeth Garrett-MayerElie G DibHerbert L DuvivierEugene R AhnDeepti BehlHossein BorghaeiAni S BalmanoukianAnu GabaRui LiKwabena Osei-BoatengRamya ThotaGina N GranthamAbigail GregorySusan HalabiRichard L SchilskyPublished in: JCO precision oncology (2023)
exon 20 insertion mutations.